Effect of Antithymocyte Globulin on Preserving Beta Cell Function in New Onset Type 1 Diabetes Mellitus.
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms START
- 18 Apr 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
- 05 Oct 2012 The primary endpoint data and additional secondary measures will be available in June 2012, and will be reported at the time of the meeting according to the abstract (however, these results were not reported in the abstract).
- 05 Oct 2012 Tolerability results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.